文献速递间质性肺疾病

囊性纤维化低体重患者肺移植后生存率可接受:UNOS登记研究

Underweight Patients With Cystic Fibrosis Have Acceptable Survival Following Lung Transplantation: A United Network for Organ Sharing Registry Study.
PubMed 文献 · Chest · 2020-01-17

BACKGROUND: Reduced BMI is an absolute contraindication for lung transplantation (LTx) at most centers in the United States.…

要点

  • CF患者肺移植后中位生存7.9年,优于COPD的5.9年和IPF的5.5年。
  • BMI<17的CF患者中位生存7.0年,校正死亡风险与BMI≥17者无显著差异。
  • BMI<17的CF患者与COPD患者死亡风险也无显著差异。

核心结论

  • CF且BMI<17 kg/m2的肺移植受者移植后生存率与其他常移植群体相当。
  • BMI<17 kg/m2作为单一危险因素不应被视为CF肺移植的绝对禁忌。

研究设计与样本

  • 采用Kaplan-Meier法估算CF、COPD和IPF患者的中位移植后生存,并按移植中心分层的Cox回归模型评估死亡风险。

主要发现

  • CF、COPD和IPF患者的中位移植后生存(95%CI)分别为7.9(7.2-8.6)年、5.9(5.6-6.2)年和5.5(5.2-5.8)年。

关键数值与推荐

  • CF患者中位移植后生存7.9年(95%CI 7.2-8.6)。
  • COPD患者中位移植后生存5.9年(95%CI 5.6-6.2)。
  • IPF患者中位移植后生存5.5年(95%CI 5.2-5.8)。

临床怎么用

  • 对CF患者进行肺移植评估时,BMI<17 kg/m2不应单独作为绝对禁忌。
  • 可参考其他常移植群体的生存数据,综合评估低体重CF患者的移植时机。

局限性

  • 研究为回顾性登记数据分析,可能存在未测量的混杂因素。
  • BMI<17 kg/m2的CF亚组样本量未在摘要中报告,结果解释需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Reduced BMI is an absolute contraindication for lung transplantation (LTx) at most centers in the United States. The objective of this study was to quantify post-LTx survival of moderate to severely underweight patients with cystic fibrosis (CF) (BMI < 17 kg/m2) in the United States relative to normal-weight recipients with CF and other frequently transplanted patient cohorts. METHODS: Using United Network for Organ Sharing Registry data (undergoing transplant from June 2005-November 2015), Kaplan-Meier estimates of median posttransplant survival were calculated for all patients with CF, COPD, and idiopathic pulmonary fibrosis (IPF), as well as low and normal weight CF subgroups. Cox regression modeling stratified according to transplant center assessed risk of posttransplant mortality in recipients with CF and a BMI < 17 kg/m2 compared with recipients with COPD (reference). RESULTS: Median posttransplant survival (95% CI) for CF, COPD, and IPF was 7.9 (7.2-8.6), 5.9 (5.6-6.2), and 5.5 (5.2-5.8) years, respectively. Although an absolute decrease was noted in posttransplant survival for recipients with CF and a BMI < 17 kg/m2, compared with those with CF and a BMI ≥ 17 kg/m2 (7.0 years [4.5-7.9] vs 8.2 years [7.3-9.0]), Cox modeling found no increased mortality risk (adjusted hazard ratio, 1.09; 95% CI, 0.90-1.32; P = .38). There was no difference in posttransplant mortality between patients with CF and a BMI < 17 kg/m2 and recipients with COPD and all BMIs (adjusted hazard ratio, 1.04; 95% CI, 0.86-1.25; P = .71). CONCLUSIONS: Transplant recipients with CF and a BMI < 17 kg/m2 had posttransplant survival rates comparable to those of other groups frequently undergoing transplantation. BMI < 17 kg/m2 as a single risk factor in the CF population should not be treated as an absolute contraindication to LTx.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Ramos KJ, Kapnadak SG, Bradford MC, et al. Underweight Patients With Cystic Fibrosis Have Acceptable Survival Following Lung Transplantation: A United Network for Organ Sharing Registry Study. Chest. 2020. PMID: 31958441. doi:10.1016/j.chest.2019.11.043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。